Literature DB >> 4248129

Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".

R L Capizzi, R C DeConti, J C Marsh, J R Bertino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4248129

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  19 in total

1.  A pharmacokinetic model for high-dose methotrexate infusions in man.

Authors:  S D Reich; N R Bachur; R H Goebel; M Berman
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  Carboxypeptidase displaying differential velocity in hydrolysis of methotrexate, 5-methyltetrahydrofolic acid, and leucovorin.

Authors:  A M Albrecht; E Boldizsar; D J Hutchison
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

3.  High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.

Authors:  F A Greco; M F Fer; R L Richardson; K R Hande; C J Van Boxtel; R K Oldham
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 4.  Clinical pharmacokinetics of methotrexate.

Authors:  D D Shen; D L Azarnoff
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

5.  Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity.

Authors:  J P Sommadossi; R Carlisle; R F Schinazi; Z Zhou
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

6.  The protein binding of methotrexate by the serum of normal subjects.

Authors:  W H Steele; J R Lawrence; J F Stuart; C A McNeill
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

7.  Mathematical modeling -- guide to high-dose methotrexate infusion therapy.

Authors:  S D Reich
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.

Authors:  N Lena; A M Imbert; T Pignon; R Favre; G Meyer; J P Cano; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  Serum, tear and salivary concentrations of methotrexate in man.

Authors:  W H Steele; J F Stuart; B Whiting; J R Lawrence; K C Calman; J G McVie; G M Baird
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

10.  Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells.

Authors:  D A Fowler; M Y Xie; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.